Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis
about
Pentraxins: structure, function, and role in inflammationC-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1α via CD64/PI3k/Akt and MAPK/ERK signaling pathways.Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo.C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.Mutations of C-reactive protein (CRP) -286 SNP, APC and p53 in colorectal cancer: implication for a CRP-Wnt crosstalk.C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results.A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancerA critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance.C-reactive protein in patients with advanced metastatic renal cell carcinoma: usefulness in identifying patients most likely to benefit from initial nephrectomy.MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption.Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal typeThe histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors.The connection between C-reactive protein and atherosclerosisConstitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer.Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers.PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice modelThe protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells.Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis.Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significanceThe modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases.C-reactive protein at the interface between innate immunity and inflammation.C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression.The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study.HDAC inhibition synergistically enhances alkylator-induced DNA damage responses and apoptosis in multiple myeloma cells.Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication.Recurrent mutations at C-reactive protein gene promoter SNP position -286 in human cancers.Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma.C-reactive protein (CRP) but not the related pentraxins serum amyloid P and PTX3 inhibits the proliferation and induces apoptosis of the leukemia cell line Mono Mac 6.Association of Soluble Interleukin-2 Receptor and C-Reactive Protein with the Efficacy of Bendamustine Salvage Treatment for Indolent Lymphomas and Mantle Cell Lymphoma.C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis.Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinoma.The Glasgow Prognostic Score (GPS) as a novel and significant predictor of extranodal natural killer/T-cell lymphoma, nasal type.Lenalidomide-induced cytokine release syndrome in a patient with multiple myeloma.
P2860
Q28676262-BD6020BF-705B-435F-BAFE-70491B55764DQ30276116-505CBD39-EBD4-4771-8087-564556DEB263Q33642712-A2FA1F8B-6367-4570-ACFF-D97F17B61CA5Q33877471-CE95609E-1C02-472A-9527-4F558B1B0F84Q33905741-EDDF9292-22BF-4010-85F4-3B0B8AB986EBQ33949736-D2FC34C9-1F10-47D2-BC07-7C3E4D99E844Q34023737-9882E928-B47E-45FD-A3AE-5929E7466120Q34293000-2F6528E5-8D7B-42F7-B7E1-6476824C1D11Q34363007-484FDC16-7906-4F53-AF6B-9FA003BADB8DQ34602557-6821D9F3-3EDD-404C-9CE0-A70B01C2B2C1Q34749502-4BC40B42-DC4F-4D4A-9486-0166201F9BE9Q35223868-F3B21B48-1072-4EAF-911C-4DAFD8A9C066Q35999439-3B4FF1E1-4456-420A-9D86-F5B3D37B20BEQ36054631-E162857D-39F5-437E-9AA2-5D2519B89D12Q36121363-5A73F71A-2098-4530-BE8E-25FF2E39D6B0Q36161907-21AC80D8-06D7-4F1F-B13C-9628F5DEC599Q36370860-CEA75FB2-3845-49D5-AD20-63A2FD9305F6Q36414357-3731163F-F814-4131-9470-77985FB9E58DQ36839558-24522A0F-247E-4DC7-B2E4-018515B0B9B7Q37223850-83BE2EBF-B9EB-43BF-8E74-77F278B80F83Q37233964-B72E52CA-D492-4B29-9751-DFF4375626BCQ37272060-AD93FB99-3D26-4068-B116-E7DFB434C678Q37327618-D2E1A9CA-DFF3-4ADB-B22A-1FF952CE3516Q37398320-79F14701-1607-48F2-8EF5-DA2DAC948068Q37618914-A47C7F53-7AA5-419A-9210-D8079225DDDAQ37683517-1055ECAD-EE41-4B1C-B4E5-A0E047AB29D7Q37754545-17E9543D-A07E-49C1-95E0-F3349D01D3B6Q38399277-AA03F80B-4618-451A-A5DA-D9B02E7E89BCQ39448618-E59E3C60-4BBC-4143-8649-56621A831EA9Q39706886-DA210256-A580-4BBE-8E80-E4DFCA9E6644Q40051813-7E828CC9-3747-4BF0-A868-EDE530AA4626Q42377898-C97ADC36-3563-4CFE-86C0-667138857C75Q43837250-47DDCCC8-CED1-4490-83E6-04CEA3C6C78CQ47162111-BDE8922A-8636-450B-9C59-D2D029B6A236Q47232472-956C34A9-7C99-49E3-9604-198D9A7ACFFAQ47300966-7CA4AFDE-D58D-4154-B5D7-89A74313C335Q47409821-77B960A0-57E2-498B-AC21-72196A9C804FQ49873955-7D4BFCC4-E6DF-43D0-A70E-0AD0BF9C899AQ53115692-9B7BB154-48F8-4521-A840-FAB419A9DAEBQ53740834-3851898A-7DFD-4A49-AA11-B4026C9F3E68
P2860
Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@ast
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@en
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@en-gb
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@nl
type
label
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@ast
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@en
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@en-gb
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@nl
prefLabel
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@ast
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@en
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@en-gb
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@nl
P2093
P3181
P1433
P1476
Human C-reactive protein binds ...... oma tumor cells from apoptosis
@en
P2093
Jianfei Qian
Larry W Kwak
Michael Wang
Michele Wezeman
Xiang Zhang
P304
P3181
P356
10.1016/J.CCR.2007.08.008
P407
P577
2007-09-01T00:00:00Z